Navigation Links
Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Date:11/6/2007

$0.29 per basic and $0.30 diluted share for the third quarter of 2006

-- As of September 30, 2007, Emisphere had $21.4 million in cash and

investments

Corporate and Product Developments

Emisphere has two Phase III products based on the compound salmon calcitonin in partnership with Novartis Pharma AG and its development partner, Nordic Bioscience:

-- One product relates to the prevention of osteoporosis and the other

product relates to the prevention of osteoarthritis

-- Osteoarthritis product has the potential to be the first disease-

modifying drug that halts progression of the illness rather than

treating symptoms

-- Both products use Emisphere's eligen(R) delivery technology to provide

salmon calcitonin for the first time as a convenient oral medication

Emisphere has three products in Phase II:

-- Development of recombinant human growth hormone ("rhGH") in

collaboration with Novartis Pharma AG

-- Continuing the development of oral heparin; discussions with the US

Food and Drug Administration ("FDA") established a pathway for

registration to proceed into complete Phase III for the use of oral

heparin in the prevention of deep-vein thrombosis following elective

total hip replacement. Emisphere is in current discussions with a

potential partner to complete the development of oral heparin in a

collaborative arrangement. Two chronic toxicology studies have been

initiated for the heparin carrier.

-- Continuing clinical development of oral insulin; insulin/glucose clamp

and oral glucose challenge studies testing a new formulation are being

planned over a three month period beginning early next year.

Collaborative partnerships will then be investigated.

Emisphere has five products in Phase I:

-- An Investigational New Drug application ("IND")
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
3. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
4. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013 Amgen (NASDAQ: ... 38 th Annual  Healthcare Conference on Thursday, May 30, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
(Date:5/23/2013)... HOUSTON , May 23, 2013  A recently ... in Houston, Texas , demonstrates that ... simultaneously increasing cancer detection. The study, ... An Observational Study," was led by Stephen ... June issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... 2013 Anthem Blue Cross patients with HIV/AIDS ... them to obtain their medications by mail order under ... Kallas LLC.  The lawsuit, filed in ... Cross,s mandatory mail order program announced late last year ... "This settlement brings to a close a ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... , CAMBRIDGE, Mass., Dec. 3, 2009 ... (NYSE: RTN ), has licensed its patented, award-winning ... FUJIFILM intends to interface the SDM technology with the Aspire ... digital mammography system will deliver stereo images for 3-D viewing. ...
... , , MAPLE ... the next phase of its strategic plan for central nervous ... developed program for the management of epilepsy. USL255 is being ... phase III clinical trial in early 2010 for the adjunctive ...
Cached Medicine Technology:Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 2Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2
(Date:5/26/2013)... "While the risk of infection following ... should be aware of the potential complications that can ... said Dr. Sadati. "It helps them to be more ... the blog, Dr. Sadati notes that less ... post-operative infection. However, patients who are undergoing any type ...
(Date:5/26/2013)... 26th May, 2013: While coupons can be ... use them. Be it due to a bad experience in ... only a few people who actually make use of coupons. ... spread awareness about coupons and allow people to use them ... there being various different opinions on why shoppers resist couponing, ...
(Date:5/26/2013)... Pain is an overall condition of sensory discomfort ... as acute pain and chronic. Pain has always been ... help. Every year about half a million people succumb ... used as primary pain relievers in which they decrease ... reducing the transmit of pain. Most common methods of ...
(Date:5/26/2013)... , , FRIDAY, May 24 (HealthDay News) -- We,ve all seen ... hurricane hits, the guy who decides to ride out the ... steer their cars alongside a scary-looking funnel cloud. Monday,s ... that Mother Nature isn,t something to gamble with -- that ... still get hurt and die. Yet, even now, when ...
(Date:5/26/2013)... May 26, 2013 According to a ... Medium Caliber & Small Caliber] (2012 – 2017)”, published ... reach $8.15 Billion by 2017 with a CACR of ... Data Tables , 87 Figures , ... “Ammunition Market” , http://www.marketsandmarkets.com/Market-Reports/ammunition-market-923.html , ...
Breaking Medicine News(10 mins):Health News:Orange County Surgeon Discusses the Risk of Infection after a Cosmetic Surgery 2Health News:Living on a Coupon Launched - Jessica Hacker Aims to Bring Professional Couponing Tips to the Masses 2Health News:Pain Management Drugs And Devices Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Pain Management Drugs And Devices Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Storm Chasers: Born to Be Wild? 2Health News:Storm Chasers: Born to Be Wild? 3Health News:Ammunition Market to Reach $8.15 Billion by 2017 at a CACR of 0.67% - New Report by MarketsandMarkets 2Health News:Ammunition Market to Reach $8.15 Billion by 2017 at a CACR of 0.67% - New Report by MarketsandMarkets 3Health News:Ammunition Market to Reach $8.15 Billion by 2017 at a CACR of 0.67% - New Report by MarketsandMarkets 4
... American Academy of Pediatrics (AAP) recommended all babies should ... deaths from Sudden Infant Death Syndrome have declined dramatically. ... and asphyxia, have increased. In an updated ... its guidelines on safe sleep for babies, with additional ...
... an association between shift work and increased risk of multiple ... age of 20 may be at risk for MS due ... Findings of this novel study appear today in Annals ... of the American Neurological Association and Child Neurology Society. ...
... the University of Sheffield is set to tackle the grand ... The FUTURAGE Road Map, created by Alan Walker, ... of Sociological Studies, will provide the European research agenda for ... was launched today at a meeting of the European Parliament ...
... more than half of cancer-free women will be among those ... about one in 12 will be referred for a biopsy. ... woman,s probability of having one of these false-positive episodes by ... over the course of a decade. A new ...
... October 17, 2011 (BRONX, NY) The Eunice ... Development, part of the National Institutes of Health, has ... Medicine of Yeshiva University $5.7 million to fund ... Disabilities Research Center (IDDRC). The grant supports Einstein,s ...
... , NEW YORK, October 17, 2011 -- Prof. ... (BGU), recently received the U.S. National Distinguished International Scientist ... Alcohol and Drug Abuse Resources (RADAR) Center. This ... National Institute on Drug Abuse (NIDA), which works with ...
Cached Medicine News:Health News:AAP expands guidelines for infant sleep safety and SIDS risk reduction 2Health News:AAP expands guidelines for infant sleep safety and SIDS risk reduction 3Health News:Shift work in teens linked to increased multiple sclerosis risk 2Health News:Project leads next decade of ageing research across Europe 2Health News:Project leads next decade of ageing research across Europe 3Health News:Project leads next decade of ageing research across Europe 4Health News:High rate of false-positives with annual mammogram 2Health News:High rate of false-positives with annual mammogram 3Health News:Einstein College of Medicine receives $5.7 million for developmental disabilities research 2Health News:BGU professor receives US National Distinguished International Science Award for substance abuse work 2
... SP Surgical Table combines innovation and design ... up to 1,000 lbs. You can safely ... normal and reverse orientation and have virtually ... patients.,The Amsco 3085 SP Table offers the ...
... 1st MPJ IMPLANT SYSTEM is a unique ... of the 1st metatarsal phalangeal joint resulting ... revision of a previous arthroplasty. The ... pain relief, superior function and longevity. ...
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
Medicine Products: